Form 8-K - Current report:
SEC Accession No. 0001096906-16-001342
Filing Date
2016-02-01
Accepted
2016-01-29 20:05:26
Documents
2
Period of Report
2016-01-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 8K 2016-01-28 aoxing8k.htm 8-K 14061
2 AOXING PHARMACEUTICAL COMPANY, INC. 8K 2016-01-28 exh101.htm EX-10.1 33399
  Complete submission text file 0001096906-16-001342.txt   49059
Mailing Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404
Business Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-32674 | Film No.: 161375110
SIC: 2834 Pharmaceutical Preparations